Thu, Sep 12, 2013
Managing Director Jim Hesburgh comments on increased mergers and acquisitions activity in the clinical research organization market.
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.